April 24th, 2018, Singapore: Lucyd Pte Ltd, the AR smartglass and software developer, is pleased to announce that Dr. William B. Trattler, M.D. has joined our science advisory board.
Dr. Trattler performs a wide variety of cataract and refractive surgeries, including PRK, femtosecond LASIK, as well as laser cataract surgery. He has been an investigator in over 60 clinical trials, including those that have led to FDA approval for both pharmaceutical agents as well as medical devices. Dr. Trattler is recognized as an expert in treating corneal diseases such as keratoconus and post-LASIK Ectasia with Corneal Collagen Crosslinking (CXL) and other procedures. His involvement in the FDA-approval study for CXL led to its approval in 2016. Dr. Trattler has also been a leader in a less invasive form of crosslinking called Epithelial-On CXL, which is working towards an FDA approval
Dr. Trattler has delivered hundreds of lectures both nationally and internationally on various topics such as: optimizing visual results with both cataract and laser vision correction, therapeutic options for patients with dry eye and blepharitis, femtosecond laser cataract surgery, corneal collagen crosslinking for keratoconus and post-LASIK ectasia, as well as advances in corneal tomography and topography for the diagnosis of ectactic corneal conditions. Dr. Trattler is the President Elect for the American European Congress of Ophthalmic Surgery (AECOS), as well as a Board Member of the Cornea Society. Dr. Trattler is the Program Director for the International Society of Refractive Surgery’s 2018 Annual Meeting.
Dr. Trattler is board certified by the American Board of Ophthalmology and has been an author of hundreds of articles and abstracts. Dr Trattler is a co-author of Microbiology Made Ridiculously Simple, a textbook used by medical, nursing and veterinary students throughout the world. In 2002, Dr. Trattler received the “Outstanding Young Ophthalmologist Leadership Award” from the Florida Society of Ophthalmology (FSO). In 2006, Dr. Trattler was recognized by his peers as one of the top 50 Cataract and Refractive Surgery Opinion Leaders in a survey conducted by the publication Cataract and Refractive Surgery Today. In 2016, he was recognized by the publication Ocular Surgery News as a Premier Surgeon 300 Innovator in Refractive Cataract Surgery. Also in 2016, Dr. Trattler was named by the publication “The Ophthalmologist” as one of the “Top 100 most influential people in the world of ophthalmology.” In addition to his private practice, Dr. Trattler is on the Volunteer Faculty at the Florida International University Wertheim College of Medicine, and has also been on the voluntary faculty of the University of Miami’s Bascom Palmer Eye Institute.
Harrison Gross, Media Lead at Lucyd said,
“We are very excited to announce that Dr. Trattler has joined our science advisory board. As a leading ophthalmologist, we look forward to his medical input and feedback on the development of Lucyd Lens smartglasses.”
Dr. Trattler said,
“I look forward to having the opportunity to contribute a medical perspective as part of the evaluation of Lucyd’s forthcoming smartglasses. Ergonomically designed smartglasses that help to enhance visual performance are certainly needed and are an exciting potential upgrade to traditional glasses.”
Lucyd PTE Ltd is developing ergonomic smartglasses and a blockchain app store to power them. The Lucyd AR blockchain platform will seek to make it easy to create, share and experience AR content. It’s time to look up from your phone and see the world. To learn more please visit https://lucyd.co.
Lucyd pte ltd is the source of this content. This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest.